Marianne Stanford, PhD

Vice President Research & Development at IMV
On the record
Represented by:
Recent Quotes
Sign up to view all
  • Now we do the next step, which is get the vaccine ready for delivery into people. We do the safety studies and the studies that really moves us from pre-clinical, into clinical. If the vaccine is proven to be safe and effective, you move quickly into the next phase of clinical study and then everything will hopefully be data driven from there.

    18 September 2020
Employment
Sign up to view all
  • IMV
    Vice President Research & Development